The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help
Open accessAbstract
Class I–restricted presentation is usually associated with cytoplasmic degradation of cellular proteins and is often considered inaccessible to exogenous antigens. Nonetheless, certain exogenous elements can gain entry into this so-called endogenous pathway by a mechanism termed cross-presentation. This is known to be effective for class I–restricted cytotoxic T lymphocyte (CTL) cross-priming directed against a variety of exogenous tumor, viral, and minor transplantation antigens. The related effect of cross-tolerance can also effectively eliminate responses to selected self components. In both cases, this presentation appears to require the active involvement of a bone marrow–derived antigen presenting cell (APC). Here, we show that CTL induction by cross-priming with cell-associated ovalbumin requires the active involvement of CD4+ helper T cells. Importantly, this CD4+ population is only effective when both the helper and CTL determinants are recognized on the same APC. Moreover, we would argue that the cognitive nature of this event suggests that the CD4+ T cell actively modifies the APC, converting it into an effective stimulator for the successful priming of the CTL precursor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Self-citationBevan, M. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.5.1283 · Cited by 956
Mice lacking MHC class II molecules
Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C., & Mathis, D. (1991) · Cell · doi:10.1016/0092-8674(91)90448-8 · Cited by 852
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Self-citationConstitutive class I-restricted exogenous presentation of self antigens in vivo.
Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F., & Kosaka, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.923 · Cited by 625
Self-citationCardin, R. D., Brooks, J. W., Sarawar, S. R., & Doherty, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.863 · Cited by 501
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
Keene, J.-A., & Forman, J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.768 · Cited by 500
A new foreign policy: MHC class I molecules monitor the outside world
Rock, K. L. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80605-0 · Cited by 403
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone, F. R., & Bevan, M. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.377 · Cited by 402
Self-citation
Cited by
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Self-citationAntigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P. (2003) · Nature · doi:10.1038/nature01441 · Cited by 1,635
CD4+ T cell help in cancer immunology and immunotherapy
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0044-0 · Cited by 1,585
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470
Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,358
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,328
Effector and Memory CTL Differentiation
Williams, M. A., & Bevan, M. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141548 · Cited by 949
Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.371 · Cited by 898
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Self-citationMHC-II neoantigens shape tumour immunity and response to immunotherapy
Alspach, E., Lussier, D. M., Miceli, A. P., Kizhvatov, I., DuPage, M., Luoma, A. M., Meng, W., Lichti, C. F., Esaulova, E., Vomund, A. N., et al. (2019) · Nature · doi:10.1038/s41586-019-1671-8 · Cited by 846
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 841
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Tay, R. E., Richardson, E. K., & Toh, H. C. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-0183-x · Cited by 813
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., & Villadangos, J. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00142.x · Cited by 735
Self-citationThe multifaceted role of CD4+ T cells in CD8+ T cell memory
Laidlaw, B. J., Craft, J. E., & Kaech, S. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.10 · Cited by 657
A Role for CD40 Expression on CD8 + T Cells in the Generation of CD8 + T Cell Memory
Bourgeois, C., Rocha, B., & Tanchot, C. (2002) · Science · doi:10.1126/science.1072615 · Cited by 640
Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation
Burgdorf, S., Kautz, A., Böhnert, V., Knolle, P. A., & Kurts, C. (2007) · Science · doi:10.1126/science.1137971 · Cited by 619
Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.693 · Cited by 610
cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity
Ferris, S. T., Durai, V., Wu, R., Theisen, D. J., Ward, J. P., Bern, M. D., Davidson, J. T., Bagadia, P., Liu, T., Briseño, C. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2611-3 · Cited by 611
Fujii, S.-I., Liu, K., Smith, C., Bonito, A. J., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040317 · Cited by 605
CD4 T Cells and Their Role in Antitumor Immune Responses
Toes, R. E. M., Ossendorp, F., Offringa, R., & Melief, C. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.753 · Cited by 508
Dendritic Cell Vaccines for Cancer Immunotherapy
Timmerman, M., & Levy, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.507 · Cited by 485
Immunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
Cross-presentation in viral immunity and self-tolerance
Heath, W. R., & Carbone, F. R. (2001) · Nature Reviews Immunology · doi:10.1038/35100512 · Cited by 480
Self-citationBelz, G. T., Behrens, G. M. N., Smith, C. M., Miller, J. F. A. P., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020861 · Cited by 467
Self-citationCognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity
Smith, C. M., Wilson, N. S., Waithman, J., Villadangos, J. A., Carbone, F. R., Heath, W. R., & Belz, G. T. (2004) · Nature Immunology · doi:10.1038/ni1129 · Cited by 448
Self-citationIs autoimmunity the Achilles' heel of cancer immunotherapy?
June, C. H., Warshauer, J. T., & Bluestone, J. A. (2017) · Nature Medicine · doi:10.1038/nm.4321 · Cited by 445
Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models
Eftimie, R., Bramson, J. L., & Earn, D. J. D. (2011) · Bulletin of Mathematical Biology · doi:10.1007/s11538-010-9526-3 · Cited by 435
Immune surveillance in multiple sclerosis patients treated with natalizumab
Stüve, O., Marra, C. M., Jerome, K. R., Cook, L., Cravens, P. D., Cepok, S., Frohman, E. M., Phillips, J. T., Arendt, G., Hemmer, B., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20858 · Cited by 434
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
French, R. R., Chan, H. T. C., Tutt, A. L., & Glennie, M. J. (1999) · Nature Medicine · doi:10.1038/8426 · Cited by 426
Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., & Gilboa, E. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-364 · Cited by 398
COOPERATION BETWEEN CD4+AND CD8+T CELLS: When, Where, and How
Castellino, F., & Germain, R. N. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115825 · Cited by 376
Scanga, C. A., Mohan, V. P., Yu, K., Joseph, H., Tanaka, K., Chan, J., & Flynn, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.347 · Cited by 350
Robust Anti-Viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions
Eickhoff, S., Brewitz, A., Gerner, M. Y., Klauschen, F., Komander, K., Hemmi, H., Garbi, N., Kaisho, T., Germain, R. N., & Kastenmüller, W. (2015) · Cell · doi:10.1016/j.cell.2015.08.004 · Cited by 337
“Both T cell subsets must interact with the same DC in an antigen- and TCR-dependent manner, meaning that the ‘‘platform’’ DC must present antigen to CD4+ and CD8+ T cells via both the MHCII and MHCI pathways, respectively (Bennett et al., 1997; Cassell and Forman, 1988).”
InfluentialKurts, C., Carbone, F. R., Barnden, M., Blanas, E., Allison, J., Heath, W. R., & Miller, J. F. A. P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2057 · Cited by 317
Self-citationGenetic models of human and mouse dendritic cell development and function
Anderson, D. A., Dutertre, C.-A., Ginhoux, F., & Murphy, K. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00413-x · Cited by 313
Cutting Edge: Bystander Apoptosis Triggers Dendritic Cell Maturation and Antigen-Presenting Function
Rovere, P., Vallinoto, C., Bondanza, A., Crosti, M. C., Rescigno, M., Ricciardi-Castagnoli, P., Rugarli, C., & Manfredi, A. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4467 · Cited by 309
Kurts, C., Miller, J. F. A. P., Subramaniam, R. M., Carbone, F. R., & Heath, W. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.409 · Cited by 309
Self-citationDatta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T., DiDonato, J., Dziarski, R., Akira, S., Schoenberger, S. P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4102 · Cited by 302
Tumor-infiltrating T lymphocytes: Friends or foes?
Yu, P., & Fu, Y.-X. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700389 · Cited by 299
Clarke, S. R., Barnden, M., Kurts, C., Carbone, F. R., Miller, J. F., & Heath, W. R. (2000) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2000.00889.x · Cited by 295
Self-citationRonchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M. P., Garancini, M. P., Manfredi, A. A., Rugarli, C., & Bellone, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.130 · Cited by 293
Identification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
Kita, H., Lian, Z.-X., Van de Water, J., He, X.-S., Matsumura, S., Kaplan, M., Luketic, V., Coppel, R. L., Ansari, A. A., & Gershwin, M. E. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010956 · Cited by 292
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming
Le Bon, A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4682 · Cited by 283
CD8+ Dendritic Cells Use LFA-1 to Capture MHC-Peptide Complexes from Exosomes In Vivo
Segura, E., Guérin, C., Hogg, N., Amigorena, S., & Théry, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1489 · Cited by 276
Tacken, P. J., de Vries, I. J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0318 · Cited by 272
Zelenay, S., Keller, A. M., Whitney, P. G., Schraml, B. U., Deddouche, S., Rogers, N. C., Schulz, O., Sancho, D., & Reis e Sousa, C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60644 · Cited by 272
Stüve, O., Marra, C. M., Bar-Or, A., Niino, M., Cravens, P. D., Cepok, S., Frohman, E. M., Phillips, J. T., Arendt, G., Jerome, K. R., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1383 · Cited by 271
Dendritic cells in cancer immunology
Murphy, T. L., & Murphy, K. M. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00741-5 · Cited by 269
Immune complex–mediated antigen presentation induces tumor immunity
Rafiq, K., Bergtold, A., & Clynes, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215640 · Cited by 232
Development and functional specialization of CD103+ dendritic cells
Del Rio, M., Bernhardt, G., Rodriguez‐Barbosa, J., & Förster, R. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00874.x · Cited by 266
Endocytosis mechanisms and the cell biology of antigen presentation
Burgdorf, S., & Kurts, C. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.12.002 · Cited by 266
DNA vaccination: antigen presentation and the induction of immunity
Shedlock, D. J., & Weiner, D. B. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.6.793 · Cited by 259
Death-defying immunity: do apoptotic cells influence antigen processing and presentation?
Albert, M. L. (2004) · Nature Reviews Immunology · doi:10.1038/nri11308 · Cited by 256
Zhang, Y., Chirmule, N., Gao, G.-P., & Wilson, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8003-8010.2000 · Cited by 119
Beavis, P. A., Henderson, M. A., Giuffrida, L., Davenport, A. J., Petley, E. V., House, I. G., Lai, J., Sek, K., Milenkovski, N., John, L. B., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0291 · Cited by 68
Protein Kinase C-θ Is an Early Survival Factor Required for Differentiation of Effector CD8+ T Cells
Barouch-Bentov, R., Lemmens, E. E., Hu, J., Janssen, E. M., Droin, N. M., Song, J., Schoenberger, S. P., & Altman, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5126 · Cited by 64
Metadata
- Authors
- Bennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., & Heath, W. R.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-07-07
- Volume
- 186
- Issue
- 1
- Pages
- 65-70
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2171986697
- Cited by
- 725
- References
- 28
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.